Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Page

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 304

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Drugs In Development, 2021, provides an overview of the Anaplastic....

USD 2000 View Report

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 97

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma - Drugs In Development, 2021, provides an overview of the Anaplastic....

USD 2000 View Report

Gliosarcoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 575

Gliosarcoma (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Drugs In Development, 2021, provides an overview of the Gliosarcoma (Oncology) pipeline....

USD 2000 View Report

Pontine Glioma (Oncology) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 649

Pontine Glioma (Oncology) - Drugs in Development, 2021Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma - Drugs In Development, 2021, provides an overview of the Pontine....

USD 2000 View Report

Neuroblastoma (Oncology) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 1265

Neuroblastoma (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma - Drugs In Development, 2021, provides an overview of the Neuroblastoma (Oncology) pipeline....

USD 2500 View Report